Sun Pharmaceutical Industries Limited

This study tested an investigational drug called SCD-044 to see if it could improve the skin and reduce itching in adults with moderate to severe eczema. For 16 weeks, 250 participants received either the drug or a placebo (an inactive substance) without knowing which one they go…

This study tested how well and how safely the prescription acne cream Winlevi works for people with darker skin tones (Fitzpatrick types IV-VI). It involved 10 participants with moderate to severe facial acne who used the cream for 16 weeks. The main goal was to see how many peop…

This study tested whether an experimental drug called SCD-044 could safely reduce the skin plaques and symptoms of moderate to severe plaque psoriasis. It involved 263 adults who were randomly assigned to receive either the drug or a placebo for 16 weeks, with some continuing for…

This study aimed to collect real-world safety information on the drug Odomzo (sonidegib) for patients with advanced basal cell carcinoma who cannot have surgery or radiation. Researchers followed 323 adult patients for up to three years in a routine clinical setting to document s…

This large, completed Phase 3 trial tested whether a single-dose injection of the drug tildrakizumab could safely reduce symptoms in adults with active psoriatic arthritis. The study involved 508 participants who had previously tried other treatments. Researchers compared the dru…

This study looked at using two prescription acne creams together in a way that mimics real-life use. Twenty people with moderate to severe facial acne used Winlevi cream alongside adapalene 0.3% gel for 16 weeks. Researchers checked how many people achieved clear or almost clear …